| [1] |
Al-Inany H, Aboulghar M, Mansour R, et al. Meta-analysis of recombinant versus urinary-derived FSH: an update[J]. Hum Reprod, 2003, 18(2):305-313.
|
| [2] |
蒋元华，段金良．丽申宝与果纳芬在IVF-ET长方案的临床比较[J]．中国性科学，2013, 22(1):29-31.
|
| [3] |
张娟，方小玲，谭小军，等. 果那芬和丽申宝在超促排卵治疗中的疗效比较[J]．生殖医学杂志，2013, 22(1):62-64.
|
| [4] |
Fulghesu AM, Apa R, Belosi C, et al. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment[J]. Horm Res, 2001, 55(5):224-228.
|
| [5] |
Streda R, Koryntová D, Mardesic T, et al. Clinical effects of recombinant versus urinary gonadotropins in ovulation induction [J]. Ceska Gynekol, 2011, 76(2):108-113.
|
| [6] |
Hugues JN, Bry-Gauillard H, Bständig B, et al. Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryotransfer [J]. J Assist Reprod Genet, 2001, 18(4):191-196.
|
| [7] |
Loumaye E, Dreano M, Galazka, et al. Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility [J]. Hum Reprod Update, 1998, 4:862-881.
|
| [8] |
Daya S, Ledger W, Auray JP, et al. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK [J]. Hum Reprod, 2001, 16(12):2563-2569.
|
| [9] |
Balasch J, Barri PN. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective [J]. J Assist Reprod Genet, 2001, 18(2):45-55.
|
| [10] |
Sunkara SK, Rittenberg V, Raine-Fenning N, et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles[J]. Hum Reprod, 2011, 26(7):1768-1774.
|
| [11] |
Stoop D, Ermini B, Polyzos NP, et al. Reproductive potential of a metaphase Ⅱ oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles [J]. Hum Reprod, 2012, 27(7):2030-2035.
|
| [12] |
Macklon NS, Fauser BC. Mild stimulation in in vitro fertilization [J]. Ann NY Acad Sci, 2003, 997:105-111.
|
| [13] |
Pellicer A, Ballester MJ. Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels [J]. Hum Reprod, 1994, 9(5):806-811.
|
| [14] |
Liu X, Hao C, Wang J. Efficacy of highly purified urinary FSH versus recombinant FSH in chinese women over 37 years undergoing assisted reproductive techniques [J]. Int J Fertil Steril, 2015, 8(4):385-392.
|
| [15] |
Mochtar MH, Van der Veen, Ziech M, et al. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles [J]. Cochrane Database Syst Rev, 2007, 18(2):CD005070-CD005070.
|
| [16] |
Matorras R, Prieto B, Exposito A, et al. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study [J]. Reprod Biomed Online, 2009, 19(6):879-887.
|
| [17] |
Hillier SG. Paracrine support of ovarian stimulation [J]. Mol Hum Reprod, 2009, 15(12):843-850.
|